Lexeo Therapeutics (LXEO) Stock: Buy, Sell, or Hold?
LXEO - Lexeo Therapeutics, Inc. Common Stock
$3.53
-0.09 (-2.49%)
▼
5d:
+6.65%
30d:
-26.15%
90d:
-23.26%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
30d
Get Alerted When LXEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LXEO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LXEO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LXEO is currently trading at $3.53, which is considered oversold relative to its 30-day fair value range of $3.65 to $4.84.
Technical Outlook: Technically, LXEO is in a downtrend. Immediate support is located at $2.98, while resistance sits at $4.33.
Market Sentiment: LXEO scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.30 (+475.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LXEO is in a downtrend. Immediate support is located at $2.98, while resistance sits at $4.33.
Market Sentiment: LXEO scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.30 (+475.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.65 -
$4.84
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 475.1% below Wall St target ($20.30)
- CAUTION: Bottoming setup, but lagging the sector by 41% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.65 -
$4.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.98
Resistance Level
$4.34
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.57
Wall Street Target
$20.30
(+475.1%)
Share & Embed Analysis
Last updated: October 04, 2026 12:31 AM ET
Data refreshes hourly during market hours. Next update: 1:31 AM
Data refreshes hourly during market hours. Next update: 1:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
